コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 is usually considered as standard great ape fare.
2 receptor alpha (PPARalpha) demonstrated that FARE-1 is a PPARalpha response element capable of confer
4 I gene promoter fatty acid response element (FARE-1) was localized to a hexameric repeat sequence loc
5 nscription factor competitively binds at the FARE and modulates fatty acid induction of the promoters
6 mplexes with oligonucleotides containing the FARE, and anti-PPARalpha antibody shifted nuclear protei
7 with CRVO (CFT >250 mum at month 3) did not fare as well as early responders if they were treated wi
8 that elderly recipients of liver allografts fare as well as their younger counterparts, but our resu
9 f life and distress, patients who choose CPM fare as well as those who do not in the first year after
13 the past decade, but black children have not fared as well as white children in large national trials
15 ts reported as having no acute rejection and fare at least as poorly as those with reported kidney gr
16 nd 12 months identified patients destined to fare badly, although criteria at 18 months were less use
19 dence-based medicine, carotid endarterectomy fares badly, with only the indications for the surgery h
21 er patients with acute myocardial infarction fare better at centers where more patients undergo prima
24 m -100% if all patients in the control group fare better than all patients in the treatment group up
25 we find that purely evolutionary techniques fare better than do model-based approaches across all bu
26 ht into the question of why some individuals fare better than others do when encountering stress in t
31 nmental as well as genetic data, will likely fare better than traditional linkage analysis in disenta
35 grafts that received Custom-I solutions also fared better (0.75, P < 0.05) than the 21.4% that had Cu
36 d in specific pathogen-free (SPF) conditions fared better against I/R-induced injury than SPF Nod2(-/
37 eir high failure rate, other cellular assays fared better and although they have not entered widespre
38 and those without graft-versus-host disease fared better as compared with their allogeneic and graft
39 e who demonstrated this immunologic response fared better clinically: 59% and 88% attained complete o
41 cal management with naltrexone, CBI, or both fared better on drinking outcomes, whereas acamprosate s
42 h tumors harboring EGFR activating mutations fared better on erlotinib alone (median PFS, 18.2 months
46 val rates than males (P = .005) and children fared better than adolescents and adults (P = .002).
49 tics as a simultaneous kidney-pancreas (SPK) fared better than diabetics receiving a kidney alone (9.
50 phageal reconstruction, patients in group II fared better than patients in group I in terms of surviv
56 rioritising immunity while older individuals fared better when maintaining high-protein nutritional p
58 , whereas patients with the lowest quartiles fared better with protocol-based care (odds ratios, 0.32
59 > or =298 g (those in the group with EF >35% fared better) but not in the group with LV mass <298 g.
62 ated datasets, the Bayesian method generally fares better than the ML approach in accuracy and covera
64 ncy in neuroprotection, with forced exercise faring better than voluntary exercise through increased
65 widespread use of smart cards for automated fare collection in these systems offers a unique opportu
67 re), 4) criterion validity (how new criteria fare compared to standards), 5) measurement burden (cost
71 ons, the EGS patients who were managed early fared equally well, if not better, than the EGS patients
72 ons that primarily reviewed POR applications fared equivalently to LOR applications; in contrast, POR
73 with detectable MRD at end of consolidation fared especially poorly, with only a 43% plus or minus 7
75 tant in their antral colonization defect and fared even worse than the Che(-) mutant in the corpus.
77 istinguishing men who are a priori likely to fare favourably with ADT from those who harbour disease
78 s in service cost, emissions, and with split fares, hinting toward a wide passenger acceptance of suc
82 sts how the efficacy findings of T2 research fare in the real world, diverse populations, and varied
83 e Institute of Medicine priority topics have fared in the agencies' funding programs, and the develop
85 years, to see how medical aid projects were faring in particular, and to assess whether the past dec
86 e Abl inhibitors dasatinib and nilotinib are faring in the treatment of imatinib-resistant CML, espec
87 ) older adults living in low-education areas fare less well cognitively than those living in high-edu
88 f the following 3 criteria, POR applications fare less well than LOR applications: (1) POR status and
91 Patients with poorly differentiated cancers fared less well than those with better differentiated le
93 s urinary incontinence by urodynamic testing fare more poorly after the most commonly offered surgica
95 nucleotide assembly-based strategy does not fare much better, as metagenomic assemblies are typicall
100 saster and the impact of social norms; women fare no better when they constitute a small share of the
101 the professionally administered intervention fared no better in terms of quality of life than patient
102 receive antibiotics for neutrocytic ascites fared no worse than patients who did receive antibiotics
105 how children with ischaemic perinatal stroke fare over time is particularly important, as there has b
107 status, and/or bone or visceral involvement fare poorly and are unlikely to benefit significantly fr
109 ant rates of mortality and morbidity and may fare poorly compared with less-invasive procedures.
110 ket (Austin, Texas) found that periodontists fare poorly on the Yelp website for nearly all measured
111 materials with excellent in-plane properties fare poorly when out-of-plane through-thickness properti
112 he best way to identify patients destined to fare poorly, thereby allowing early clinical interventio
118 ry in Afghanistan who returned to duty still fared quite poorly on many clinical outcome measures 6-1
119 ited Kingdom suggests that cancer drugs have fared quite well, with most recommendations being positi
121 concern because patients discharged at night fare significantly worse than those discharged during th
123 in Level 2, patients with anxious depression fared significantly worse in both the switching and augm
124 3 abnormalities, infants younger than 1 year fared significantly worse than patients 1 year of age or
125 patients who received whole-pelvis treatment fared significantly worse than those in the other two gr
126 t 8% of the intensity of normal lymphocytes) fared significantly worse than those with lower-density
127 1 to 0.28; P<.001), while non-Fusarium cases fared similarly (regression coefficient=0.02 logMAR; 95%
128 e tissue complications of aging and diabetes fared since the identification of the link between these
129 H1 and FBXW7 mutant-positive patients do not fare sufficiently well to warrant an individualized trea
131 s analysis shows that African American males fared the worst, with lives characterized by incarcerati
132 rent prices for similar services (e.g., full-fare vs. advanced-purchase plane tickets, full tuition v
133 A promoter fatty acid response element (FARE) was mapped, mutation of which ablated fatty acid-m
134 ancer patients with venous thrombosis do not fare well and have an increased mortality compared with
135 neration of Aurora kinase inhibitors did not fare well in clinical trials, owing to poor efficacy and
140 Regrettably, neither of the 2 approaches has fared well in animal experiments, and the only clinical
144 o high levels of posttraining fear tended to fare worse at the follow-up if they received methylene b
148 In general, patients with carcinosarcomas fare worse than patients with carcinomas of the same ana
149 ile receiving medication, children with ADHD fare worse than their peers across a wide range of outco
150 er septic conditions, PAD4(-/-) mice did not fare worse than wild-type mice and had comparable surviv
151 vation and, in contrast to other xenografts, fare worse when the complement of the graft recipient is
152 )-methylguanine-DNA methyltransferase (MGMT) fare worse, presumably because of temozolomide resistanc
153 ith alveolar RMS or undifferentiated sarcoma fare worse; however, FFS and overall survival are substa
156 for functional capacity, in which etanercept fared worse than the other treatments: steroids vs. etan
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。